...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

But:

Biogen's Aducanumab targets the amyloid-beta plagues.

Not sure what Apabetalone targets to slow down cognitive impairment. 

 

Koo

 

Share
New Message
Please login to post a reply